Tags: Heart Disease | blood thinner | vorapaxar | clinical trials | Zontivity | heart-related deaths

New Blood Thinner Gets Preliminary FDA OK

Monday, 13 Jan 2014 12:30 PM

 


Merck & Co Inc's experimental blood clot-preventing drug vorapaxar should be approved, based on "robustly positive" clinical trial results, according to a preliminary review of the data by the U.S. Food and Drug Administration.
 
The review, posted on the FDA's website on Monday, comes two days ahead of a meeting of outside medical experts, who are expected to recommend whether it should be approved. The FDA usually follows the advice of its advisory panels.

The drug, which would be sold under the brand name Zontivity, is designed to prevent heart-related deaths, cardiac arrests and strokes in patients who have had a recent heart attack but not a stroke.
 
Results from a trial known as TRA 2P "are sufficient to establish the effectiveness of vorapaxar for its proposed indication," the review found.
 
The main safety concern with the drug is bleeding, the review found, though it noted that the rate of fatal bleeding was low in the population for whom the drug is being proposed.
 
The FDA did not recommend that the company establish a risk management program, nor did it recommend that the company conduct additional trials following approval.

© 2015 Thomson/Reuters. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

MRI Improves Prostate Cancer Biopsy Accuracy

Tuesday, 27 Jan 2015 16:34 PM

Prostate biopsies that combine MRI technology with ultrasound appear to give men better information regarding the seriou . . .

Medication for Low Thyroid Condition Gets FDA Approval

Tuesday, 27 Jan 2015 12:41 PM

A new drug has been approved to raise calcium levels in patients with low thyroid conditions. The U.S. Food and Drug Adm . . .

Combo Blood Pressure Treatment OKd by FDA

Tuesday, 27 Jan 2015 12:34 PM

A new combination pill to treat people with high blood pressure has won approval from the U.S. Food and Drug Administrat . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved